![Ken Warrington](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ken Warrington
Directeur/Membre du Conseil chez
BIOSTEM TECHNOLOGIES, INC.
Fortune : 124 855 $ au 31/08/2026
Profil
Ken Warrington is currently Director at BioStem Technologies, Inc. since 2022, with employment at the company starting in 2019.
Former roles include Chief Technology Officer at Lacerta Therapeutics, Inc. from 2017 to 2019, Head-Strategy & Innovations at Genscript Probio Usa, Inc. from 2020 to 2021, and Senior VP-Operations & Business Development at Biostem Life Sciences, Inc. from 2019 to 2020.
Education includes a doctorate from the University of Florida conferred in 2000 and an undergraduate degree from The St. Lawrence College conferred in 1993.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/09/2026 | 33 928 ( 0,19% ) | 124 855 $ | 31/08/2026 |
Postes actifs de Ken Warrington
| Sociétés | Poste | Début |
|---|---|---|
| BIOSTEM TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 01/03/2022 |
Anciens postes connus de Ken Warrington
| Sociétés | Poste | Fin |
|---|---|---|
GENSCRIPT PROBIO USA INC.
 GENSCRIPT PROBIO USA INC. BiotechnologyHealth Technology Genscript Probio Usa, Inc. is a private company based in Pennington, NJ. The company was founded in 2017. | Corporate Officer/Principal | 01/12/2021 |
Biostem Life Sciences, Inc. | Directeur des opérations | 01/05/2020 |
Lacerta Therapeutics, Inc.
 Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Directeur Technique/Scientifique/R&D | 01/05/2019 |
Formation de Ken Warrington
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioStem Technologies, Inc.
 BioStem Technologies, Inc. BiotechnologyHealth Technology Develops stem cell based medical therapies | Health Technology |
The St. Lawrence College
 The St. Lawrence College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lacerta Therapeutics, Inc.
Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
GENSCRIPT PROBIO USA INC.
GENSCRIPT PROBIO USA INC. BiotechnologyHealth Technology Genscript Probio Usa, Inc. is a private company based in Pennington, NJ. The company was founded in 2017. | Health Technology |
Biostem Life Sciences, Inc. |
